Ratings by Laidlaw
| Date | Analyst | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|---|
| 7/13/2026 | Yale Jen | NewcelX AG | NCEL | New Coverage | Buy (N/A) |
23.00 (N/A) |
4.13 (3.81) |
-7.75% | Details |
| 4/15/2026 | Yale Jen | Kazia Therapeutics | KZIA | New Coverage | Buy (N/A) |
25.00 (N/A) |
8.99 (14.15) |
57.4% | Details |
 |
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
| 167 more... | |||||||||
